FOLH1 and prostate carcinoma: Prostate cancer expresses a high number of TAAs, such as prostate-specific membrane antigen (PSMA), prostatic acid phosphatase (PAP), prostate-specific antigen (PSA) or six-transmembrane epithelial antigen of the prostate-1 (STEAP1).